Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors.
about
Molecular Biomarkers in the Personalized Treatment of Colorectal Cancer.The dynamic DNA methylation landscape of the mutL homolog 1 shore is altered by MLH1-93G>A polymorphism in normal tissues and colorectal cancer.Tumors with unmethylated MLH1 and the CpG island methylator phenotype are associated with a poor prognosis in stage II colorectal cancer patientsCpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers.Impact of LINE-1 hypomethylation on the clinicopathological and molecular features of colorectal cancer patients.
P2860
Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Clinicopathologic Risk Factor ...... ation in CIMP-Positive Tumors.
@ast
Clinicopathologic Risk Factor ...... ation in CIMP-Positive Tumors.
@en
type
label
Clinicopathologic Risk Factor ...... ation in CIMP-Positive Tumors.
@ast
Clinicopathologic Risk Factor ...... ation in CIMP-Positive Tumors.
@en
prefLabel
Clinicopathologic Risk Factor ...... ation in CIMP-Positive Tumors.
@ast
Clinicopathologic Risk Factor ...... ation in CIMP-Positive Tumors.
@en
P2093
P2860
P50
P1476
Clinicopathologic Risk Factor ...... lation in CIMP-Positive Tumors
@en
P2093
A Joan Levine
Amanda I Phipps
Daniel J Weisenberger
Dennis J Ahnen
John A Baron
Noralane M Lindor
Peter W Laird
Robert W Haile
Stacey A Cohen
P2860
P356
10.1158/1055-9965.EPI-15-0935
P577
2015-10-28T00:00:00Z